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Abstract
Background: The expression of some genes controlling energy homeostasis could be regulated by epigenetic 
mechanisms that may play a role in body weight regulation. Thus, it is known that various nutritional factors affect DNA 
methylation. In order to assess whether the macronutrient composition of the diet could be related to the epigenetic 
regulation of gene expression and with obesity development, we investigated the effects on methylation and 
expression patterns of two pair-fed isocaloric diets in rats: control (rich in starch) and HFS (rich in fat and sucrose).
Results: The pair-fed HFS diet induced higher weight gain and adiposity as compared to the controls as well as liver 
triglyceride accumulation and oxidative stress. Feeding the HFS diet impaired glucose tolerance and serum 
triglycerides and cholesterol. Liver glucokinase expression, a key glycolytic gene, remained unaltered, as well as the 
mRNA values of fatty acid synthase and NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 6 (NDUFB6) in liver 
and visceral adipocytes, which regulate lipogenesis and mitochondrial oxidative metabolism, respectively. Liver 
expression of hydroxyacyl-coenzyme A dehydrogenase (HADHB), a key gene of β-oxidation pathway, was higher in the 
HFS-fed animals. However, the methylation status of CpG islands in HADHB and glucokinase genes remained 
unchanged after feeding the HFS diet.
Conclusions: These results confirm that the distribution and type of macronutrients (starch vs. sucrose, and percent of 
fat) influence obesity onset and the associated metabolic complications. HFS diets produce obesity independently of 
total energy intake, although apparently no epigenetic (DNA methylation) changes accompanied the modifications 
observed in gene expression.
Background
Excessive weight gain arises from the interactions among
environmental factors (dietary intake and physical activ-
ity), genetic predisposition and the individual behaviours
[1]. Thus, a sedentary lifestyle and unhealthy diet con-
sumption (high saturated fat and refined carbohydrates)
are important determinants for the increasing prevalence
of the metabolic syndrome and associated complications,
namely type 2 diabetes, dyslipemia and cardiovascular
diseases [2]. In fact, studies by Barnard et al. [2,3] have
documented that the syndrome can be induced in rats by
feeding a high-fat-sucrose (HFS) diet similar to the typi-
cal US diet. Furthermore, trials in rats have clearly shown
the capacity of diets rich in simple sugars to reduce insu-
lin sensitivity [4].
Among the different mechanisms that could lead to
interindividual differences in fat deposition and obesity,
the epigenetic regulation of gene expression has emerged
in the last years as a potentially important contributor [1].
Exposure to nutritional, chemical, and physical factors
has been postulated to influence these epigenetic events,
contributing to modify the gene expression profile and
potentially altering disease risks [5]. Thus, changes in
DNA methylation patterns could be a result of the inter-
play of various dietary and environmental factors and
also could be the cause of inter-individual differences
concerning the susceptibility to develop obesity and other
metabolic diseases [1]. In this context, not only the intake
of methyl donors (betaine, choline, methionine, zinc, and
folate) are likely to alter DNA methylation, but also some
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macronutrients such as fatty acids intake could be
involved [6].
The potential reversibility of DNA methylation makes
epigenetics an attractive target for therapeutic interven-
tion [7]. The role of epigenetic factors in the regulation of
gene expression makes epigenetics a major topic of inter-
est in the onset, development and therapy of diseases
such as cancer, type 2 diabetes and obesity [8]. In this
context, different human genes have been described as
regulated by epigenetic mechanisms in relation to meta-
bolic diseases [1], such as HSD11B2 (hypertension),
PPARG (atherosclerosis) or PPARGC1 (diabetes). Other
genes involved in the development of obesity, such as lep-
tin [9] and TNF-alpha [10], have been found to be regu-
lated by epigenetic mechanisms influences by the diet or
obesity. Other metabolic gene that is regulated by epige-
netic mechanisms is NDUFB6. Thus, Ling et al. [11] dem-
onstrated that NDUFB6 DNA methylation patterns are
associated with an age-dependent decline in its expres-
sion in human skeletal muscle, opening up the possibility
that epigenetic marks such as DNA methylation could
predispose an individual to insulin resistance and type 2
diabetes mellitus. NADH dehydrogenase (ubiquinone) 1
beta subcomplex, 6 (NDUFB6) codifies for an inner mito-
chondrial membrane protein involved in mitochondrial
electron transport [12].
Glucokinase (GCK) is a key gene in energy homeostasis
involved in glucose phosphorylation in liver as the first
step of the glycolytic pathway, and whose expression is
activated in patients with type 2 diabetes [13]. Epigenetic
regulation of this gene has been recently reported [14]
although it has not been studied in nutritional studies.
Furthermore, hydroxyacyl-coenzyme A dehydrogenase
(HADHB) catalyzes two steps in mitochondrial fatty acid
oxidation and its deficiency causes abnormal fatty acid
metabolism [15]. Whether this gene may be regulated by
epigenetic mechanisms is yet to be determined.
In summary, in order to unveil some of these questions,
we have generated an animal model (HFS), whose caloric
intake is similar to the control group, but varying in their
macronutrient composition, since HFS diet provides
more fat and sucrose and less starch than the C diet. The
aim of this study was to test whether differences in
dietary macronutrient composition can induce changes
in the methylation patterns of several key metabolic
genes, and whether these epigenetic processes could be
related to changes in gene expression of these genes and
on obesity development.
Results
Metabolic effects
By design, no differences in energy intake were found
between both experimental groups. However, the animals
fed a HFS diet increased their weights up in 209.2 ± 12.0
g, whereas the control group only gained 158.5 ± 7.2 g,
being the differences statistically significant (p < 0.01).
Moreover, neither energy expenditure nor the respiratory
quotient were different between the two groups (Table 1).
The HFS diet significantly decreased total cholesterol
(p < 0.01) and HDL-cholesterol (p < 0.001) levels as well
as serum triglycerides (p < 0.05) as compared to the con-
trol group (Table 2). No differences in fasting glucose,
FFA, lactate, insulin and adiponectin were observed.
Thiobarbituric acid reactive substance (TBARS), a
marker of liver lipid peroxidation, was higher (p < 0.05) in
the HFS-fed group. This finding was related to an
increase in liver triglycerides (Table 2), suggesting an
impairment in liver metabolism as well as hepatic steato-
sis. In fact, a close correlation (p < 0.001) was found
between both variables.
During the experimental trial (at week 5), when still no
differences appeared in body weight between both
groups, an intraperitoneal glucose tolerance test was per-
formed. These results suggested that an incipient devel-
opment of insulin resistance in the HFS animals (Figure
1).
After sacrifice, marked weight differences between
both experimental groups were observed in several adi-
pose tissue depots: subcutaneous, retroperitoneal, mes-
enteric and epididymal. As expected, the adiposity was
higher in HFS Group as compared to C animals (Figure
2). Visceral fat was determined as the sum of retroperito-
neal, mesenteric and epididymal fat and was also signifi-
cantly higher (p < 0.001) in the HFS group (33.60 ± 1.86 g)
respect to C (21.74 ± 1.35 g).
Table 1: Food intake, respiratory quotient and energy expenditure in both experimental groups (C and HFS)
Control HFS T test
Weight gain 158.50 ± 7.22 209.25 ± 12.05 **
Food intake at the end of the treatment (Kcal/d 75.1 ± 1.8 72.5 ± 2.9 NS
Respiratory quotient 0.73 ± 0.0 0.72 ± 0.0 NS
Energy expenditure (Kcal/d/bw ¾) 116.6 ± 2.8 125.7 ± 3.7 NS
NS: not statistically significant; d: day; bw: body weight. Data are given as mean ± SEM. Control vs. HFS: * p < 0.05.Lomba et al. Lipids in Health and Disease 2010, 9:60
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Gene Expression
Additionally, the liver mRNA levels of four genes were
analyzed: HADHB, GCK, FAS and NDUFB6. Interest-
ingly, the HADHB expression was statistically higher (p <
0.05) in the group fed a HFS diet as compared to C group.
No statistical differences were found in the other three
genes, GCK, FAS and NDUFB6, despite a slight increase
in GCK expression (Figure 3). The mRNA levels of FAS,
NDUFB6 and HADHB were also analyzed in epididymal
adipose tissue, although no differences were observed
between both dietary group (data not shown).
DNA Methylation
When analysing the methylation pattern of GCK in liver
and HADHB in liver and epididymal fat, no relevant dif-
ferences were found between the dietary groups (Figure
4).
Discussion
The current trial asserts the important role of the dietary
macronutrient distribution on weight gain. Indeed, the
amount and composition of the ingested food appeared
to influence body-weight regulation [16]. Thus, the HFS
group showed a statistically significant increase in body
weight at the end of the dietary treatment compared with
the C group, in spite of isocaloric intake. Other studies
have reported comparable results in rodents fed ad libi-
tum with a similar diet [3], but apparently never within a
pair-fed model. In fact, a pair-feeding model of HFS diet
was performed in Sprague-Dawley rats, although no
changes in body weight gain were observed [17]. The
strongest evidence of the experimental hypothesis comes
from rodent studies in which a high-fat (HF) diet induced
obesity independently of total energy intake [18,19]. This
k i n d  o f  e x p e r i m e n t s  i s  v e r y  d i f f i c u l t  t o  p e r f o r m  i n
humans.
Our results confirm that the dietary distribution and
the type of macronutrients (starch vs. sucrose and unsat-
urated vs. saturated fats) could influence the development
of metabolic disorders. Thus, when the intraperitoneal
glucose overload was performed, the curve of glucose tol-
erance was higher and prolonged in time in the HFS
group, as described by other authors after consuming ad
libitum HFS [20], HF [21] and high sucrose diets [22]. In
this context, in ad libitum dietary models, insulin resis-
tance appeared after 2 weeks, without important changes
in plasma triglycerides, plasma glycerol, or blood pres-
sure, even before any indication of obesity or adipocyte
hypertrophy [2]. Thus, Grimditch et al. [23] previously
reported that, of the two main components of the HFS
diet, refined sugar caused a greater problem than the high
fat content during glucose tolerance tests. However, the
combination of high fat and high refined sugar resulted in
an ever worse response.
On the other hand, Barnard et al. [2] have demon-
strated that the insulin resistance onset occurs before
other metabolic syndrome manifestations, being the
dietary intake, but not excessive weight gain, the underly-
ing cause. In addition, studies in humans have also indi-
cated that insulin resistance usually precedes other
aspects of the metabolic syndrome such as dyslipidemia
and hypertension [24]. In this context, it is likely that at
the time of intraperitoneal glucose overload, the HFS
group was developing a preliminary state of insulin resis-
tance, characterized by a lower insulin sensitivity unable
to compensate glucose overloads. However, in the fasting
condition after sacrifice, no differences in serum insulin
levels were observed.
Total and HDL-cholesterol circulating levels signifi-
cantly decreased in the HFS group dietary treatment.
This reduction could be, in part, the result of the lower
HDL cholesterol levels, as has been previously reported
Table 2: Serum and liver measurements in the C and HFS experimental groups
Control HFS T test
Glucose (mg/dL) 107.5 ± 2.2 109.5 ± 3.8 NS
Cholesterol (mg/dL) 76.6 ± 4.2 59.5 ± 2.8 **
HDL-C (mg/dL) 25.6 ± 1.0 19.4 ± 0.7 ***
FFA (mmol/L) 0.7 ± 0.05 0.7 ± 0.05 NS
Lactate (mg/dL) 17.8 ± 1.2 22.4 ± 2.9 NS
Serum triglycerides (mg/dL) 98.8 ± 5.9 80.7 ± 4.6 *
Insulin (μg/L) 1.0 ± 0.2 1.2 ± 0.2 NS
Adiponectin (μg/mL) 8.84 ± 2.48 8.19 ± 1.39 NS
Liver TBARS (mM TBARS/g liver) 0.95 ± 0.01 1.43 ± 0.20 *
Liver triglycerides (mmol/L) 2.53 ± 0.20 5.07 ± 0.43 ***
NS: not statistically significant; TBARS: thiobarbituric acid reactive substance. Data are given as mean ± SEM. Control vs. HFS: * p < 0.05; ** p 
< 0.01; *** p < 0.001.Lomba et al. Lipids in Health and Disease 2010, 9:60
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by Boqué et al. [25] using a similar diet (ad libitum) in
Wistar rats, although these differences were not statisti-
cally significant. It is known that the type of dietary car-
bohydrate (starch versus sucrose) [26] and the type of fat
i n  t h e  d i e t  [ 2 7 ]  a f f e c t  c h o l e s t e r o l  m e t a b o l i s m  i n  r a t s .
Likewise, the serum triglyceride levels were significantly
lower in the HFS group as compared to C, as other
authors have previously described with a HFS diet. Thus,
Boqué et al. [25] reported a similar outcome in Wistar
rats fed a HFS diet ad libitum for 35 days, Yamamoto et
al. [28] in Sprague-Dawley rats fed a HFS diet during 4
weeks, and Jourdan et al. [29] in mice fed for more than
20 weeks. These results suggest an increase in TG clear-
ance by the liver and adipose tissue, and confirm the lipid
metabolism differences between rodent and human mod-
els.
In relation to hepatic TG, it has been reported that the
consumption of one-third more calories in the form of
dietary fat but not carbohydrates produces steatosis in
rats [30]. These authors indicate that the delivery and uti-
lization of this extra fat by the liver in the HF ad libitum
group provides the first hit in the development of Non-
Alcoholic Fatty Liver Disease (NAFLD) in Sprague-Daw-
ley rats.
In this context, TBARS is considered a reliable marker
of cellular lipid peroxidation [31]. Our results demon-
strate that HFS intake induces an increase in liver TBARS
in comparison with the animals fed on the C group.
Other authors have reported similar increases in oxida-
tive stress with ad libitum HFS [28], HF [32] and cafeteria
diets [33]. Lipid peroxidation leads to reduced hepatic
mitochondrial oxidative capacity and increased suscepti-
bility to hepatic steatosis and injury [34]. In this sense,
saturated fatty acids may promote endoplasmic reticulum
stress and hepatocyte injury resulting in hepatic dysfunc-
tion in rodents [35]. The inflammatory status related to
obesity may be also originated by oxidative stress, which
induces cell injury and could be able to dysregulate adipo-
cytokine production and insulin sensitivity [36].
Concerning mRNA studies in liver, HADHB gene
expression was significantly increased in HFS animals as
compared to C. This gene encodes an inner mitochon-
drial membrane protein made up of α and β subunits that
contributes to three of the four reactions necessary for
mitochondrial long-chain fatty acid β-oxidation [37]. The
β-subunit shows 3-oxoacyl-CoA thiolase activity, and the
α-subunit provides enoyl-CoA hydratase and 3-hydroxy-
acyl-CoA dehydrogenase activity. Concerning dietary
Figure 1 Intraperitoneal glucose tolerance test performed in HFS and C groups. After glucose administration (1g/Kg bw), the blood glucose lev-
els were measured at 0, 15, 30, 60, and 120 min. Results are expressed mean ± SEM. Control vs. HFS: * p < 0.05; ** p < 0.01; *** p < 0.001
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regulation of this gene, Oshida et al. [38] reported that
HADHB activity in muscle was higher in rats fed a high
sucrose diet. According to them, the high sucrose group
exhibited a metabolic pattern in muscle that favoured
carbohydrate over fat oxidation. A later study in humans
demonstrated that HADHB activity increased when the
palmitate oxidation occurred [39]. These results suggest
that this enzyme performance is increased in the pres-
ence of fatty acids.
Regarding to GCK gene expression, we observed a
slight increase (although not statistically significant) in
the HFS group, similarly to others authors [40]. Glucoki-
nase catalyses the first and rate-limiting step in glycolysis:
the phosphorylation of glucose to glucose-6-phosphate.
In the liver, GCK activity determines the rate of glucose
utilization and glycogen synthesis [41]. In rats, diets
enriched in fat or sucrose are able to: 1) reduce the ability
of insulin to suppress glucose production in vivo, 2)
decrease the ability of insulin to suppress gluconeogene-
sis in liver, and 3) increase the capacity for gluconeogene-
sis from a number of precursors in liver [42,43]. The
importance of GCK in humans is evidenced by the fact
that heterozygous loss-of-function mutations cause
maturity-onset diabetes of the young type 2 (MODY 2), a
disease characterized by early-onset and persistent
hyperglycaemia [44].
With regard to epigenetic studies, no changes in
HADHB and GCK methylation patterns were observed.
Apparently, we are the first to investigate the possible
HADHB epigenetic regulation, while, in relation to GCK,
only one publication has addressed the study of the meth-
ylation of this gene, although in relation to the aging pro-
cess [14].
In this context, Ling C et al. [11] demonstrated that
NDUFB6 DNA methylation played a role in the patho-
genesis of insulin resistance and type 2 diabetes mellitus.
However, we have not found differences in relation to
dietary macronutrient changes.
Conclusions
The main conclusion of this work is that the different
macronutrient distribution of the diet, with no differ-
ences in terms of total energy intake, may play an impor-
tant role in weight gain and metabolic syndrome
manifestations, by affecting the expression of key energy
metabolism genes. However, the methylation patterns in
the investigated gene regions remained apparently unaf-
fected, suggesting that gene expression changes are not
likely to be due to modifications in DNA methylation.
Methods
Animal and Diets
Eight-weeks-old male Wistar rats (initial weight 254g ± 4;
n = 24), supplied by the Applied Pharmacobiology Center
(CIFA, Pamplona, Spain), were individually housed at 21-
23°C and controlled (50 ± 10%) humidity under a 12 h
Figure 2 Weight of various organs and tissues after sacrifice. RP, retroperitoneal; SC, subcutaneous. Results are expressed as mean ± SEM. Control 
vs. HFS: ** p < 0.01; *** p < 0.001
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artificial light cycle (8 a.m. to 8 p.m.) The animals were
randomly assigned to two different dietary groups: Con-
trol and High Fat Sucrose (HFS). The control animals (n =
12) were fed a standard pelleted diet (2014 Tekland
Global 14% Protein Rodent Maintenance Diet, Harlan
Ibe ri ca,  Ba r c e lo na, S pain ) c o n ta ining  20% of  e ner gy as
proteins, 67% of energy as carbohydrates (5% sucrose,
62% starch) and 13% of energy as fat by dry weight, while
the HFS group (n = 12) was fed a high fat sucrose diet
(D12451, Research Diets, New Brunswick, NJ, USA). The
composition of this diet was 20% of energy as protein,
35% as carbohydrates (18% sucrose, 10% maltodextrin
and 7% starch) and 45% as lipids by dry weight.
During the experimental trial, the HFS group received a
diet restricted to the amount of calories (kcal / [g body
weight]) that the C group had consumed the day before
(pair-fed  model), as previously described [19]. Body
weight and food intake were daily recorded.
In vivo experiments
At week 5, two gas exchange determinations (oxygen [O2]
consumption and carbon dioxide [CO2]) were performed
by using an Oxylet 00 O2/CO2 indirect calorimeter (Pan-
lab SL, Barcelona, Spain) as previously described [45].
Also, after a fasting period of 12 h, rats fed the HFS and C
diets were intraperitoneally injected with glucose at 1g/kg
body weight [46]. We collected blood from tail veins at 0,
15, 30, 60, and 120 min after glucose administration in
order to determine blood glucose levels with a Glucose-
meter device (Roche Diagnostic, Mannheim, Germany).
At the end of the experimental period (69 days), rats
were sacrificed by decapitation. Blood and tissue samples
were immediately collected and stored at -80°C for fur-
ther analyses. All the procedures were performed accord-
ing to national and institutional guidelines of the Animal
Care and Use Committee at the University of Navarra.
Serum and Liver analysis
Circulating total and HDL-cholesterol were measured
with Cholesterol CP and HDL direct CP (ABX diagnostic,
Montpellier, France) respectively in a COBAS MIRA
equipment (Rochel, Basel, Switzerland). Serum triglycer-
ides and lactate were measured with a Randox kit and a
L-Lactate kit, respectively (Randox, LTD Laboratories,
Ardmore Road, UK). FFA (free fatty acids) were quanti-
fied with a NEFA C kit (Wako Chemicals, Neuss, Ger-
many). Lipid peroxidation was measured as
thiobarbituric acid reactive substance (TBARS assay Kit,
Cayman Chemical Company, USA) after sonicating for 15
seconds at 40 V in RIPA buffer with protease inhibitors
and centrifugating at 1.600 × g for 10 minutes at 4°C.
Liver triglycerides levels were determined by a colorimet-
ric assay (Triglycerides MR, Cromatest; Linear Chemi-
Figure 3 GCK, HADHB, FAS and NDUFB6 mRNA expression. GCK, HADHB, FAS and NDUFB6 mRNA expression values measured by RT-PCR in liver 
from Control and HS Groups. All results are expressed as fold of change as compared to controls (control set at unity), and shown as mean ± SEM. 
Control vs. HFS: * p < 0.05
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Figure 4 Methylation percentages of GCK and HADHB genes. Methylation percentages obtained for each of the CpGs analyzed for GCK (above) 
and HADHB (below) in liver. There were no statistically significant differences induced by the dietary groups. In GCK gene, CpG 7 levels were not iden-
tified in the analysis. CpG 2 and CpG 3 were not identified in HADHB gene analysis. Not detected, ND. Results are expressed mean ± SEM
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Table 3: Primer sequences for quantitative analysis of the degree of DNA methylation using the MassARRAY system
Gene Forward primer (5' 3') Reverse primer (3' 5')
GCK TAGAATTAGGGAGGAAGTAGGAAGG GGATTTTGAGGTATTGTATTGATTTTT
HADHB TTTTTTTATTAGTAGGAAAAGGGTAGT GGGTTGATTTTTGAATAAGATTTGALomba et al. Lipids in Health and Disease 2010, 9:60
http://www.lipidworld.com/content/9/1/60
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cals, Spain) after 15 seconds sonication at 40 V in Tris-Cl
buffer. Serum adiponectin (Linco Research, St Charles,
MO, USA) and insulin levels (Mercodia AB, Uppsala,
Sweden) were measured by ELISA in an automatized
TRITURUS equipment (Grifols International S.A., Barce-
lona, Spain).
Gene Expression analysis
Total RNA was isolated from epididymal adipose tissue
and liver according to Tri® manufacturer's instructions
(Sigma-Aldrich, Missouri, USA). DNase treatment was
performed with a DNA-free™ kit (Applied Biosystems,
Austin, TX, USA), and cDNA synthesized using M-MLV
reverse transcriptase (Invitrogen, Carlsbad, CA, USA) as
described by the suppliers. Quantitative Real-Time PCR
assays were performed following manufacturer's recom-
mendations using an ABI PRISM 7000 HT Sequence
Detection System and Taqman probes for rat HADHB
(Rn00592435_m1), GCK (Rn00688285_m1), FAS
(Rn01463550_m1) and NDUFB6 (Rn03416136_m1). The
gene expression levels were normalized with ubiquitin
(Rn01789812_g1) and GAPDH (Rn 99999916_s1)
mRNAs as internal controls (Applied Biosystems, Austin,
TX, USA) and using the Genorm software [47]. Fold
change between HFS and control rats was calculated
using the 2-ΔΔCt method.
DNA Methylation analysis
The quantitative analysis of GCK and HADHB degree of
DNA methylation was determined by using the MassAR-
RAY system (San Diego, CA, USA), which combines base
specific enzymatic cleavage with MALDITOF Sequenom
mass spectrometry technology [48], after bisulphite treat-
ment (Epitect kit, Qiagen, Valencia, CA, USA). Primers
used are shown in Table 3.
The following two sequences were analyzed: GCK gene,
with 8 CpGs, and HADHB, with 6CpGs (Table 4). They
are numbered 1-8 and 1-6 respectively in the text and fig-
ures.
Statistic analysis
Results are presented as means ± SEM of the means. Sta-
tistical analyses were performed using SPSS 15.0 pack-
ages of Windows (Chicago, IL, USA). Data were analysed
by the student-T test. The Pearson correlation coefficient
was used to assess the relationship between liver TBARS
and triglyceride levels. Statistical significance was set-up
at the P < 0.05 level.
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